Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU - Wikidata - wikimedia - TriplyDB

Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU

Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU

http://www.wikidata.org/entity/Q34487220

about

Invasive candidiasis in critical care setting, updated recommendations from "Invasive Fungal Infections-Clinical Forum", Iran.Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study.Bloodstream infections in the Intensive Care Unit.Association between pathogens from tracheal aspirate and oral biofilm of patients on mechanical ventilation.Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.Candidemia in non-ICU surgical wards: Comparison with medical wards.Seven years of clinical experience with the Yeast Traffic Light PNA FISH: Assay performance and possible implications on antifungal therapy.Treatment of Invasive Candidiasis: A Narrative Review

P2860

Q34452343-04B75E8C-962B-4D64-8219-102C9DD4B290 Q36441468-2450F442-009C-41A3-BED0-37622C0D0087 Q36913336-4A51CB22-2073-4635-BD9D-347DC26FDE10 Q40181657-960805E7-B428-4C84-82D1-FD824C29E8D5 Q41031258-C8AAC957-0C33-4EF3-B6A3-0B2C712E33DD Q42680559-1C7DF338-9A08-4642-A450-938422AB0644 Q47685703-D6074D86-BBFF-4DDE-AFAD-DFF86A45513B Q58772447-D4546897-8647-4FDE-BE7E-A4DA17BF4E89

P2860

Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU

http://www.wikidata.org/entity/Q34487220

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Empirical antifungal therapy w ...... ed strategy in one medical ICU

@ast

Empirical antifungal therapy w ...... ed strategy in one medical ICU

@en

Empirical antifungal therapy w ...... ed strategy in one medical ICU

@nl

type

label

Empirical antifungal therapy w ...... ed strategy in one medical ICU

@ast

Empirical antifungal therapy w ...... ed strategy in one medical ICU

@en

Empirical antifungal therapy w ...... ed strategy in one medical ICU

@nl

prefLabel

Empirical antifungal therapy w ...... ed strategy in one medical ICU

@ast

Empirical antifungal therapy w ...... ed strategy in one medical ICU

@en

Empirical antifungal therapy w ...... ed strategy in one medical ICU

@nl

P1433

Q34487220-BF31D205-3A73-474A-9608-1A4ED38F0A14

P1476

Q34487220-04EC75C0-395D-48AC-AD47-0D46C4C6C6F4

P2093

Q34487220-1303CAF3-97A6-4C59-9A64-BBF3081CA050

Q34487220-15D83056-6357-44F9-8958-9600012CE2B2

Q34487220-4F695797-47BA-4466-BA46-1739DB20F17D

Q34487220-62505E42-1196-433B-BC70-423CA8A0F36E

Q34487220-6286014A-CCF2-475A-8712-258165B1A7E5

Q34487220-633A932C-562F-4925-B04E-D16EFAB3129A

Q34487220-D9C7678C-A482-4D1C-BD19-886DAAAA8B56

Q34487220-F0159A40-1B82-4D0E-8A9E-A61CEA52FAB9

P2860

Q34487220-003818DB-07BA-46E9-91D1-B15A338A18D9

Q34487220-027BE0D1-ECEB-493F-A559-BB08BF680B49

Q34487220-0E5A615C-C0FE-4C55-87B5-E58B80C92151

Q34487220-0F6B2243-6A89-428E-BB2D-775863E6BD45

Q34487220-15FBF973-3A65-45B6-82CD-C330295A1C3F

Q34487220-18AEF469-6725-4480-951C-6F5DFC849D8D

Q34487220-39FA0C81-0C0F-4BBE-8898-42CE15A2A145

Q34487220-4614D660-A75F-4892-8E88-EAEA17847DF5

Q34487220-539A39A4-4FE6-442B-8BE5-7C683B118AF3

Q34487220-5525A74C-1BD7-4B4B-AC2F-45219BE8E8C8

P2888

Q34487220-8E61964D-111E-49C3-9E6A-8327E26D68E7

P304

Q34487220-036513B3-9598-4F7D-9953-56939D9ACB68

P31

Q34487220-44AC35F8-010C-4793-9B2F-0665FB746948

P356

Q34487220-DD3E84F6-8182-4A80-A1FA-2396FB7D8827

P478

Q34487220-04D10180-4D05-4434-93EC-C73F95916582

P577

Q34487220-A100AF4E-1D38-4EBA-8F1A-3C800B32C266

P5875

Q34487220-62F63CB0-3A08-4A64-B430-778581C21B61

P6179

Q34487220-D7EFE72D-DD65-4723-9E40-5D3C001859DF

P698

Q34487220-3A55DC18-C6B3-4C6C-A51F-BBEA346CCAAF

P932

Q34487220-A6B68820-DFC8-4FB3-98E1-DFA3FC8E5E5D

P356

1471-2334-14-385

P1433

BMC Infectious Diseases

P1476

Empirical antifungal therapy w ...... ed strategy in one medical ICU

@en

P2093

Clara Vigneron

http://www.w3.org/2001/XMLSchema#string

Cristobal Leon

http://www.w3.org/2001/XMLSchema#string

Frédéric Dalle

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Quenot

http://www.w3.org/2001/XMLSchema#string

Pierre-Emmanuel Charles

http://www.w3.org/2001/XMLSchema#string

Rémi Bruyère

http://www.w3.org/2001/XMLSchema#string

Serge Aho

http://www.w3.org/2001/XMLSchema#string

Sébastien Prin

http://www.w3.org/2001/XMLSchema#string

P2860

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index.

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting.

Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.

Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.

Fungal sepsis in the ICU: are we doing better? Trends in incidence, diagnosis, and outcome.

P2888

1471-2334-14-385

P304

385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-14-385

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263860829

http://www.w3.org/2001/XMLSchema#string

P6179

1035985649

http://www.w3.org/2001/XMLSchema#string

P698

25015848

http://www.w3.org/2001/XMLSchema#string

P932

4227296

http://www.w3.org/2001/XMLSchema#string